By Bryan Koenig (October 18, 2021, 9:06 PM EDT) — The trade group for the generic-drug industry has joined Impax Laboratories in asking the U.S. Supreme Court to overturn a Fifth Circuit decision upholding the Federal Trade Commission’s claim that an agreement the generic maker cut with Endo Pharmaceuticals Inc. over the opioid pain medication Opana ER ran afoul of antitrust laws.
The Association for Accessible Medicines, the trade lobby for manufacturers of generic-drugs as well as biosimilar versions of large molecule biologic therapies, filed an amicus brief Friday backing Impax Laboratories’ bid for high court intervention. In addition to attacking the company’s Fifth Circuit loss on the merits, AAM also argued that…
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Lucknow: The Lucknow bench of the Allahabad high court while refusing anticipatory bail to a government doctor, observed that corruption was a termite in every system and once it entered the system, it went on increasing. Rejecting the anticipatory bail of a government doctor, justice Krishna Pahal observed on February 25: “Corruption is a termite […]
New Delhi: The Supreme Court on Monday allowed the CBI to proceed with the probe into the suicide of a 17-year-old girl in Thanjavur who was allegedly coerced to convert to Christianity. A bench of Justices Sanjiv Khanna and Bela M Trivedi issued notice on the appeal filed by the Tamil Nadu DGP challenging the […]
The top court noted that the proceedings before the NCLT are at stage 8, meeting of shareholders, and that there are 15 stages for the final approval of the scheme. The top court granted liberty to Future Retail to move the high court seeking continuation of proceedings before NCLT beyond Stage 8. “Approach the Delhi […]
